Reneo Pharmaceuticals, Inc.
Reneo Pharmaceuticals, Inc. (RPHM) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 58 transactions totaling $35.6M, demonstrating a bullish sentiment with $32.0M in net insider flow. The most recent transaction on Sep 25, 2024 involved a purchase of 68,746 shares valued at $103.1K.
RPHM Insider Activity Summary
Who Is Buying RPHM Stock?
No significant insider buying has been recorded for RPHM in the recent period.
Who Is Selling RPHM Stock?
No significant insider selling has been recorded for RPHM in the recent period.
Is Reneo Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for RPHM is bullish with an Insider Alignment Score of 95/100 and a net flow of $32.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
RPHM Frequently Asked Questions
Understanding RPHM Insider Activity
Insider trading at Reneo Pharmaceuticals, Inc. (RPHM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading RPHM stock, having executed 58 transactions in the past 90 days. The most active insider is Holdings A/s Novo (Executive), who has made 3 transactions totaling $10.7M.
Related Tools
Track Reneo Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at RPHM file new Form 4 transactions